Table 3 Changes to Costs, QALYs and NMB as compared to current practice
From: The clinical value and cost-effectiveness of treatments for patients with coronary artery disease
Change to Costs (95% UI) | Change to QALYs (95% UI) | NMB (95% UI) | |
|---|---|---|---|
100% patients starting with CABG | $10,040 (9766–10,314) | 2.19 (2.14–2.23) | $164,957 (161,241–168,673) |
100% patients starting with OMT | -$3661 (-3700–3622) | -0.09 (-0.1–0.08) | -$13,630 (-17,270–9990) |
100% patients starting with PCI | $18,789 (18,484–19,093) | -0.21 (-0.26–0.17) | -$36,080 (-39,715–32,445) |
Recommended Policy | -$1743 (-1808 -1678) | 0.23 (0.22–0.24) | $20,240 (19,637–20,844) |